S&P 500   3,145.87 (-0.30%)
DOW   26,200.66 (+0.44%)
AAPL   378.23 (-0.96%)
GOOGL   1,490.28 (-1.45%)
AMZN   2,976.04 (-4.12%)
NVDA   395.26 (-1.70%)
CGC   17.00 (-1.73%)
MU   48.31 (-2.33%)
GE   6.71 (+0.15%)
T   30.02 (+0.84%)
F   6.21 (+2.31%)
BAC   24.01 (-0.74%)
S&P 500   3,145.87 (-0.30%)
DOW   26,200.66 (+0.44%)
AAPL   378.23 (-0.96%)
GOOGL   1,490.28 (-1.45%)
AMZN   2,976.04 (-4.12%)
NVDA   395.26 (-1.70%)
CGC   17.00 (-1.73%)
MU   48.31 (-2.33%)
GE   6.71 (+0.15%)
T   30.02 (+0.84%)
F   6.21 (+2.31%)
BAC   24.01 (-0.74%)
S&P 500   3,145.87 (-0.30%)
DOW   26,200.66 (+0.44%)
AAPL   378.23 (-0.96%)
GOOGL   1,490.28 (-1.45%)
AMZN   2,976.04 (-4.12%)
NVDA   395.26 (-1.70%)
CGC   17.00 (-1.73%)
MU   48.31 (-2.33%)
GE   6.71 (+0.15%)
T   30.02 (+0.84%)
F   6.21 (+2.31%)
BAC   24.01 (-0.74%)
S&P 500   3,145.87 (-0.30%)
DOW   26,200.66 (+0.44%)
AAPL   378.23 (-0.96%)
GOOGL   1,490.28 (-1.45%)
AMZN   2,976.04 (-4.12%)
NVDA   395.26 (-1.70%)
CGC   17.00 (-1.73%)
MU   48.31 (-2.33%)
GE   6.71 (+0.15%)
T   30.02 (+0.84%)
F   6.21 (+2.31%)
BAC   24.01 (-0.74%)
Log in

NASDAQ:ESTAEstablishment Labs Stock Price, Forecast & News

$15.66
+0.16 (+1.03 %)
(As of 07/14/2020 09:55 AM ET)
Add
Compare
Today's Range
$15.66
Now: $15.66
$16.58
50-Day Range
$15.50
MA: $18.28
$20.76
52-Week Range
$7.56
Now: $15.66
$29.78
Volume22,900 shs
Average Volume52,526 shs
Market Capitalization$365.35 million
P/E RatioN/A
Dividend YieldN/A
Beta1.46
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.
Read More
Establishment Labs logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.09 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ESTA
CUSIPN/A
CIKN/A
Phone506 2434 2400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$89.57 million
Book Value$1.92 per share

Profitability

Net Income$-38,150,000.00

Miscellaneous

Employees505
Market Cap$365.35 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive ESTA News and Ratings via Email

Sign-up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.

Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions

How has Establishment Labs' stock been impacted by COVID-19 (Coronavirus)?

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA stock has increased by 3.4% and is now trading at $15.66. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Establishment Labs?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Establishment Labs.

When is Establishment Labs' next earnings date?

Establishment Labs is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Establishment Labs.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc (NASDAQ:ESTA) issued its earnings results on Thursday, May, 7th. The company reported ($0.79) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.49. The company earned $24.48 million during the quarter, compared to analysts' expectations of $23.10 million. Establishment Labs had a negative return on equity of 75.95% and a negative net margin of 48.39%. View Establishment Labs' earnings history.

What price target have analysts set for ESTA?

3 equities research analysts have issued 1-year price targets for Establishment Labs' stock. Their forecasts range from $20.00 to $35.00. On average, they expect Establishment Labs' share price to reach $26.00 in the next twelve months. This suggests a possible upside of 66.0% from the stock's current price. View analysts' price targets for Establishment Labs.

Has Establishment Labs been receiving favorable news coverage?

Media coverage about ESTA stock has trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Establishment Labs earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Establishment Labs.

Who are some of Establishment Labs' key competitors?

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

Who are Establishment Labs' key executives?

Establishment Labs' management team includes the following people:
  • Mr. Juan Jose Chacon Quiros, Founder, CEO & Exec. Director (Age 47)
  • Mr. Salvador Santos Dada, Chief Operating Officer (Age 37)
  • Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 36)
  • Ms. Renee M. Gaeta, Chief Financial Officer (Age 38)
  • Mr. Roberto De Mezerville, Chief Technology Officer (Age 39)

When did Establishment Labs IPO?

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

How do I buy shares of Establishment Labs?

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $15.66.

How big of a company is Establishment Labs?

Establishment Labs has a market capitalization of $365.35 million and generates $89.57 million in revenue each year. The company earns $-38,150,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. Establishment Labs employs 505 workers across the globe.

What is Establishment Labs' official website?

The official website for Establishment Labs is www.establishmentlabs.com.

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.